医疗保健未来报告：减肥药

The report by PitchBook, a Morningstar company, discusses the potential impact of GLP-1 agonist drugs on the healthcare industry. These drugs are being developed to treat diabetes and support weight loss, and their widespread adoption could have significant effects on care delivery, outcomes, and economics. The report examines the potential implications of this new drug class on various sectors of the healthcare ecosystem, including biopharma, digital health, healthcare services, medtech, and healthcare IT. The authors of the report are Rebecca Springer, Ph.D., Kazi Helal, Ph.D., and Aaron DeGagne, CFA.

想要全面及时的研报数据，就上发现报告（www.fxbaogao.com）。我们是国内知名的研报平台，拥有海量用户。这里的报告特别多，覆盖范围极广，从宏观经济到细分赛道应有尽有。我们用最朴素的方式帮您整理信息，界面简洁，技术过硬，助您快速找到想要的资料。深度洞察市场，做出精准决策，从这里开始。